American Institute for Advanced Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,096
Closed -$260K 120
2023
Q2
$260K Buy
+7,096
New +$276K 0.23% 102
2023
Q1
Sell
-8,011
Closed -$410K 111
2022
Q4
$410K Buy
8,011
+675
+9% +$32.4K 0.38% 72
2022
Q3
$321K Hold
7,336
0.3% 75
2022
Q2
$385K Hold
7,336
0.34% 74
2022
Q1
$380K Buy
7,336
+65
+0.9% +$3.37K 0.28% 79
2021
Q4
$429K Hold
7,271
0.29% 77
2021
Q3
$313K Sell
7,271
-85
-1% -$3.77K 0.22% 92
2021
Q2
$288K Sell
7,356
-1,175
-14% -$45.7K 0.2% 95
2021
Q1
$309K Buy
8,531
+1,010
+13% +$35.9K 0.24% 86
2020
Q4
$277K Sell
7,521
-259
-3% -$9.5K 0.22% 86
2020
Q3
$271K Sell
7,780
-1,475
-16% -$51.7K 0.24% 82
2020
Q2
$287K Buy
9,255
+316
+4% +$10.7K 0.27% 74
2020
Q1
$277K Sell
8,939
-1,280
-13% -$43.6K 0.3% 72
2019
Q4
$380K Buy
+10,219
New +$364K 0.37% 62

Other funds holding PFE

American Institute for Advanced Investment Management's PFE Position: Q3 2023 in Review

American Institute for Advanced Investment Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 7,096 shares — an estimated $260K sold.

American Institute for Advanced Investment Management first reported a position in PFE in Q4 2019 and held it in 14 quarters. The position peaked at $429K in Q4 2021. 2,927 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • American Institute for Advanced Investment Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • American Institute for Advanced Investment Management sold 7,096 Pfizer shares in Q3 2023, an estimated $260K.
  • American Institute for Advanced Investment Management first reported a position in Pfizer in Q4 2019 and held it in 14 quarters.
  • American Institute for Advanced Investment Management's Pfizer position peaked at $429K in Q4 2021.
  • 2,927 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on American Institute for Advanced Investment Management's 13F filing for Q3 2023, filed 31 Oct 2023.